Quick Answer
Ardent Health, Inc. reported Cash and Equivalents of $709.60 million for fiscal year 2025.
Ardent Health, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $709.60M | +27.4% |
| 2024 | $556.78M | +27.2% |
| 2023 | $437.58M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $609.44M | +8.2% | +12.7% |
| June 30, 2025 | $540.63M | +61.6% | +9.2% |
| March 31, 2025 | $495.04M | — | -11.1% |
| December 31, 2024 | $556.78M | +27.2% | -1.1% |
| September 30, 2024 | $563.14M | — | +68.3% |
| June 30, 2024 | $334.54M | — | -23.5% |
| December 31, 2023 | $437.58M | — | — |
- Ardent Health, Inc. showed an increase of +27.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Ardent Health, Inc.’s cash and equivalents has grown by 62.2% (from $437.58 million to $709.60 million).
- The most recent figure is from Ardent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: